Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
1999-08-25
2009-08-04
Shibuya, Mark L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S007100, C435S007200, C435S007600, C435S007720, C435S007940, C503S223000, C503S223000, C503S223000
Reexamination Certificate
active
07569338
ABSTRACT:
A rapid and convenient method for detecting inflammatory conditions in breast tissue, such as those associated with mastitis, is described. The method comprises measuring the presence and quantity of Serum Amyloid A (SAA) in milk samples obtained from the breast tissue. The amount of SAA present in the milk is positively correlated with the level of inflammation of the breast tissue, and can localize the inflammation to a particular region of the breast organ, such as a specific quadrant of a cow's udder. Test kits and their use in the method are also described.
REFERENCES:
patent: 4755380 (1988-07-01), Grubb
patent: 4952496 (1990-08-01), Studier
patent: 5227302 (1993-07-01), Turner
patent: 5536640 (1996-07-01), Sipe et al.
patent: 5807684 (1998-09-01), Simmons et al.
patent: 5853985 (1998-12-01), Salbaum
patent: 5952313 (1999-09-01), Carlson
patent: 5958883 (1999-09-01), Snow
patent: 6004936 (1999-12-01), Kisilevsky
patent: 6013857 (2000-01-01), Deboer
patent: 0 872 558 (1998-10-01), None
patent: 1 067 194 (2001-01-01), None
patent: WO/95/21625 (1995-08-01), None
patent: PCT/JP96/02219 (1996-07-01), None
patent: WO/97/04317 (1997-02-01), None
patent: WO/97/06184 (1997-02-01), None
patent: WO/98/03206 (1998-01-01), None
patent: WO/98/40506 (1998-09-01), None
patent: WO/99/18227 (1999-04-01), None
patent: WO/01/14580 (2001-03-01), None
patent: WO/01/31006 (2001-03-01), None
Jacobsen et al. Kinetics of Local and systemic isoforms or serum amyloid A in bovine mastitis milk. Veterinary Immunology & Immunopathology 104 (2005) 21-31.
Bowie, “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science 247:1306-1310 (1990).
Kluve-Beckerman, “Nonexpression of the Human Serum Amyloid A Three (SAA3) Gene”, DNA and Cell Biology, 10(9):651-661 (1991).
McDonald, “A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein”, J. of Immunolog. Methods, 144:149-155 (1991).
Pedersen, “The biology of eukaryotic promoter prediction-a review”, Computers & Chemistry 23:191-207 (1999).
Sack, “The human serum amyloid A (SAA)-encoding gene GSAA1:nucleotide sequence and possible autocrine-collagenase-inducer function”, Gene, 84:509-515 (1989).
Skolnick, “From Genes to Protein Structure and Function: Novel Applications for Computational Approaches in the Genomic Area”, TIBTECH 18:34-39 (2000).
Bowie, James U., et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science 247:1306-10 (1990).
Skolnick, Jeffrey et al., “From genes to protein structure and function: novel applications of computational approaches in the genomic era”, TIBTECH 18:34-39 (2000).
Bauman et al., “The acute phase response”, IT Review, 1994 Elsevier Science Ltd, 0167-5699/94.
Benson et al., “A unique insertion in the primary structure of bovie amyloid AA protein”, J. Lab ClinMed, vol. 113, pp. 67-72, 1989.
Hulten et al., “The acute phase serum amyloid A protein (SAA) in the horse: isolation and characterization of three isoforms”, Veterinary Immunology and Immunopathology 57, 215-227, 1997.
Jensen et al., “Regulation of serum amyloid A protein expression during the actue-phase response”, Biochem J. 334, 489-503, 1998.
Kho et al., GenBank Submission AAF77630, serum amyloid A protein, (Bos Taurus).
Kho et al., Rapid Communication: Cloning of bovine serum amyloid A# cDNA1, American Society of Animal Science, May 19, 2000.
Kho et al., “Cloning and characterization of involution-specific genes from the bovine mammary gland” Database EMBL ′Online! Database accession No. AF160867; Jun. 30, 2000.
Kluve-Beckerman et al., “Human sermu amyloid A—Three Hepatic mRNAs and the corresponding proteins in one person”, The Journal of Clinical Investigation, vol. 82, pp. 1670-1675, 1988.
Kluve-Beckerman et al., “Primary structures of dog and cat amyloid A proteins: comparison to Human AA”, Comp. Biochem Physiol. B, vol. 94, pp. 175-183, 1989.
Kluve-Beckerman et al., “Sequence Analysis of a Third Human SAA gene”, Database CAPLUS on STN, meeting abstract, 1991.
Larson et al., “Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence”, pp. 531-540, Biochemical and Biophysical Research Communications 300, Elsevier Science, 2002.
Larson et al., “Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide”, pp. 1030-1037, Biochemical and Biophysical Research Communications 301, Elsevier Science, 2003.
Liang et al., “Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells”, Journal of Lipid Research 37:2109-2116, 1996.
Liepnieks et al., “The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloid A proteins in other species”, J Lab Clin Med, 118(6):570-576, 1991.
McDonald et al., “Elevated extrahepatic expression and secretion of mammary-associate serum amyloid A3 (M-SAA3) into colostrums”, Veterinary Immunology and Immunopathology 6528, 2001.
Malle, E., “Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice”, European Journal of Clinical Investigation 26:427-435, 1996.
Marhaug et al., “Mink serum amyloid A protein. Expression and primary structure based on cDNA”, J. Biol. Chem., vol. 265, 10049-10054, 1990.
Migita, K., et al., “Serum Amyloid A Protein Induces Production of Matrix Metalloproteinases by Human Synovial Fibroblasts”, Laboratory Investigation, 78(5): 535-539, 1998.
Mitchell et al., “Serum Amyloid A SAA3 produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum”, Journal of Clinical Investigation, vol. 87, No. 4, pp. 1177-1185, XP000992756, 1991.
Mitchell et al., “The acute phase reactant serum amyloid A (SAA3) is a novel substrate for digradation by the metalloproteinases collagenase and stromelysin”, Biochem et Biophysica Acta., 1156:245-254, 1993.
Patel, H., “Human Serum Amyloid A has Cytokine-like Properties”, Scand. J. Immunol., 48:410-418, 1998.
Peristeris, P., “Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture”, Biochem. Cell Biol. 67:365-370, 1989.
Rossevatn, et al., “The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A”, Scand. J. Immunol., 35(2), 217-24, 1992.
Rygg et al., “In vitro evaluation of an enhanced Human Serum Amyloid A (SAA) Promoter-regulated soluble TNF Receptor Fusion Protein for Anti-inflammatory Gene Therapy”, Scand J Immunol, 2001.
Sellar et al., “Oganization of the Region Encompassing the Human Serum Amyloid A (SAA) Gene Famil on Chromosome 11”, Genomics, vol. 23, pp. 492-495, 1994.
Sletten et al., “The amino acid sequence of an amyloid fibril protein AA isolated from the horse”, Scand. J. Immunol. 26, 79-84, 1987.
Sletten et al., “The primary structure of equine serum amyloid A (SAA) protein”, Scand. J. Immunol., vol. 30, pp. 117-122, 1989.
Smith, J., et al., “Comparison of Serum Amyloid A and C-Reactive Protein as Indicators of Lung Inflammation in Corticosteroid Treated and Non-Corticosteroid Treated Cystic Fibrosis Patients”, Journal of Clinical Laboratory Analysis 6:219-224, 1992.
Smith, J. et al., “Use of Ethanol-Eluted Hydrophobic Interaction Chromatography in the Purification of Serum Amyloid A”, Protein Expression and Purification 2:158-161, 1991.
Smith, J. et al., “Production of serum amyloid A and C-reactive protein by HepG2 c
McDonald Thomas L.
Weber Annika
Accuplex, LLC.
Do Pensee T
McKee Voorhees & Sease, P.L.C.
Shibuya Mark L
LandOfFree
Diagnostic assays of secreted biological fluids for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic assays of secreted biological fluids for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic assays of secreted biological fluids for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4085095